Healthcare Realty Trust (NYSE:HR – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.590-1.65 for the period, compared to the consensus estimate of 0.230. The company issued revenue guidance of -.
Healthcare Realty Trust Stock Performance
HR stock traded up $0.53 during trading on Friday, reaching $19.23. 6,069,074 shares of the company traded hands, compared to its average volume of 3,530,513. Healthcare Realty Trust has a 12 month low of $14.09 and a 12 month high of $19.43. The business has a 50 day simple moving average of $18.00 and a 200 day simple moving average of $17.70. The company has a market capitalization of $6.71 billion, a price-to-earnings ratio of -27.08 and a beta of 0.97.
Healthcare Realty Trust (NYSE:HR – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.02. Healthcare Realty Trust had a negative return on equity of 5.07% and a negative net margin of 20.84%.The company had revenue of $275.28 million for the quarter, compared to the consensus estimate of $283.01 million. During the same quarter last year, the company earned $0.39 earnings per share. The firm’s revenue for the quarter was down 7.7% compared to the same quarter last year. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. As a group, research analysts forecast that Healthcare Realty Trust will post 1.61 EPS for the current year.
Healthcare Realty Trust Announces Dividend
Analyst Upgrades and Downgrades
HR has been the subject of several recent research reports. UBS Group initiated coverage on Healthcare Realty Trust in a research report on Monday, April 20th. They set a “neutral” rating and a $18.00 price target for the company. Wall Street Zen upgraded Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Cantor Fitzgerald lifted their price target on Healthcare Realty Trust from $19.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, February 17th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Healthcare Realty Trust in a research report on Friday, March 27th. Three investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Healthcare Realty Trust currently has a consensus rating of “Hold” and a consensus price target of $18.78.
Read Our Latest Stock Report on Healthcare Realty Trust
Insider Buying and Selling
In other Healthcare Realty Trust news, Director Thomas N. Bohjalian acquired 10,000 shares of the company’s stock in a transaction on Friday, March 6th. The shares were bought at an average cost of $18.09 per share, with a total value of $180,900.00. Following the completion of the acquisition, the director owned 85,520 shares in the company, valued at approximately $1,547,056.80. This trade represents a 13.24% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.56% of the company’s stock.
Trending Headlines about Healthcare Realty Trust
Here are the key news stories impacting Healthcare Realty Trust this week:
- Positive Sentiment: Raised FY‑2026 normalized FFO per share to $1.59–$1.65 and increased same‑store NOI growth target to 3.75%–4.75% — management pushed up forward fundamentals, which supports valuation and cash‑flow expectations. Healthcare Realty targets $1.59-$1.65 2026 normalized FFO per share as it raises same-store NOI growth to 3.75%-4.75%
- Positive Sentiment: Declared a quarterly dividend of $0.24 per share (annualized yield ~5.0%), with record date May 11 and payable May 22 — enhances income appeal for yield-seeking investors.
- Positive Sentiment: Beat EPS estimates: Q1 EPS of $0.41 vs. consensus $0.39; company issued a press release and slide deck highlighting results and the guidance raise. Healthcare Realty Reports First Quarter 2026 Results and Increases Full Year 2026 Guidance
- Neutral Sentiment: Full Q1 earnings call transcript available for detail on portfolio performance and leasing/occupancy commentary — useful for assessing sustainability of the raised outlook. Healthcare Realty Trust Incorporated (HR) Q1 2026 Earnings Call Transcript
- Neutral Sentiment: Independent Q1 snapshot coverage summarizes results and context for the quarter — good for quick read of operational takeaways. Healthcare Realty Trust: Q1 Earnings Snapshot
- Negative Sentiment: Revenue missed estimates: Q1 revenue $275.3M vs. consensus $283.0M and was down ~7.7% year‑over‑year; the company reported a negative net margin and negative ROE — these trends could pressure long‑term growth expectations if persistent. Healthcare Realty Trust Q1 earnings details
Institutional Trading of Healthcare Realty Trust
A number of institutional investors have recently made changes to their positions in HR. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Healthcare Realty Trust in the first quarter worth approximately $205,000. Empowered Funds LLC acquired a new stake in shares of Healthcare Realty Trust in the first quarter worth approximately $202,000. Invesco Ltd. boosted its stake in shares of Healthcare Realty Trust by 48.9% in the second quarter. Invesco Ltd. now owns 2,307,109 shares of the real estate investment trust’s stock worth $36,591,000 after acquiring an additional 757,542 shares during the last quarter. First Trust Advisors LP boosted its stake in shares of Healthcare Realty Trust by 314.1% in the second quarter. First Trust Advisors LP now owns 223,125 shares of the real estate investment trust’s stock worth $3,539,000 after acquiring an additional 169,248 shares during the last quarter. Finally, Amundi boosted its stake in shares of Healthcare Realty Trust by 154.0% in the second quarter. Amundi now owns 519,816 shares of the real estate investment trust’s stock worth $8,343,000 after acquiring an additional 315,179 shares during the last quarter.
About Healthcare Realty Trust
Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.
The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.
Featured Articles
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.
